Supportive care 2030 movement: towards unifying ambitions for global excellence in supportive cancer care—an international Delphi study
Year: 2024
Type: article
Abstract: Background: Supportive care to ensure optimal quality of life is an essential component of cancer care and symptom control across the lifespan. Ongoing advances in cancer treatment, increasing toxicity from many novel treatment regimes, and variations in access to care and cancer outcomes across the globe and resource settings present significant challenges for supportive care delivery. To date, no overarching framework has been developed to guide supportive care development worldwide. As an initial step of the Multinational Association of Supportive Care in Cancer (MASCC) Supportive Care 2030 Movement, we developed a targeted, unifying set of ambition statements to envision the future of supportive cancer care. Methods: From September 2022 until June 2023, we used a modified Delphi methodology to develop and attain consensus about ambition statements related to supportive cancer care. Leaders of MASCC Study Groups were invited to participate in an Expert Panel for the first two Delphi rounds (and a preliminary round to suggest potential ambition statements). Patient Advocates then examined and provided input regarding the ambition statements. Findings: Twenty-seven Expert Panelists and 11 Patient Advocates participated. Consensus was attained on 13 ambition statements, with two sub-statements. The ambition statements addressed global standards for guideline development and implementation, coordinated and individualized care, dedicated supportive oncology services, self-management, needs for screening and actions, patient education, behavioral support, financial impact minimization, comprehensive survivorship care, and timely palliative care, reflecting collaboration, coordination and team-based approach across all levels. Interpretation: This study is the first to develop shared ambitions for the future of supportive cancer care on a global level. These ambition statements can facilitate a coordinated, resource-stratified, and person-centered approach and inform research, education, clinical services, and policy efforts. Funding: This project received funding support from Prof Raymond Chan's NHMRC Investigator Grant (APP1194051).
Source: EClinicalMedicine
Authors: Raymond Javan Chan, Reegan Knowles, Fredrick D. Ashbury, Joanne Bowen, Alexandre Chan, Melissa Chin, Ian Olver, Carolyn Taylor, Stacey Tinianov, Paola Alberti, Paolo Bossi, Norman Brito-Dellan, Tim Cooksley, Gregory Brian Crawford, Niharika Dixit, Margaret I. Fitch, Jason L. Freedman, Pamela K. Ginex, Nicolas H. Hart, Daniel L. Hertz, Michael Jefford, Bogda Koczwara, Tateaki Naito, Andrea Dahlman Orsey, Christina H. Ruhlmann, Nikolaos Tsoukalas, Corina van den Hurk, Ysabella Van Sebille, Hannah Rose Wardill, Florian Scotte, Maryam Lustberg
Institutions: Flinders University, Caring Futures Institute, University of Calgary, The University of Adelaide, University of California, Irvine, Multinational Association of Supportive Care in Cancer, Azienda Ospedaliera San Gerardo, University of Milano-Bicocca, Humanitas University, IRCCS Humanitas Research Hospital, The University of Texas MD Anderson Cancer Center, San Francisco General Hospital, University of California, San Francisco, University of Toronto, Children's Hospital of Philadelphia, University of Pennsylvania, State University of New York, Stony Brook University, University of Technology Sydney, University of Michigan, The University of Melbourne, Peter MacCallum Cancer Centre, Flinders Medical Centre, Shizuoka Cancer Center, University of Connecticut, Connecticut Children's Medical Center, UConn Health, University of Southern Denmark, Odense University Hospital, 401 General Military Hospital of Athens, Netherlands Comprehensive Cancer Organisation, University of South Australia, South Australian Health and Medical Research Institute, Institut Gustave Roussy, Yale University, Smilow Cancer Hospital
Language: English
Topic: Cancer survivorship and care
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $5,000
Funders: Amgen, Pfizer, Sanofi, Gilead Sciences, American Society of Clinical Oncology, Helsinn, Les Laboratories Pierre Fabre, Fondazione Cariplo, Vifor Pharma, Otsuka Pharmaceutical, Ono Pharmaceutical, LEO Pharma, National Institutes of Health, National Health and Medical Research Council, National Center for Advancing Translational Sciences
OpenAlex ID: W4402441558